About: Familial hyperlipoproteinaemias - correlation between genotype and phenotype III.

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Familial hyperlipoproteinaemias - correlation between genotype and phenotype III. Goto Sponge NotDistinct Permalink

An Entity of Type : http://linked.opendata.cz/ontology/domain/vavai/Projekt, within Data Space : linked.opendata.cz associated with source document(s)

Attributes	Values
rdf:type	http://linked.opendata.cz/ontology/domain/vavai/Projekt
rdfs:seeAlso	http://www.isvav.cz/projectDetail.do?rowId=NB5986
Description	Study of familial hyperlipoprotenaemias and their phenotypic expression in relation to genotype findings. Evaluation of utilize of genetics in clinical practise. Monitoring of statin efficacy in prevention of cardiovascular diseases. (en) Studie familiárních hyperlipoproteinémií a jejich fenotypických nálezů ve vztahu k nálezům v genotypu. Posouzení možnosti vyuřití genetiky, včetně molekulární biologie v klinické praxi. Sledování účinků léčby v prevenci kardiovaskulárních nemocí
Title	Familial hyperlipoproteinaemias - correlation between genotype and phenotype III. (en) Familiární hyperlipoproteinémie - korelace genotypu a fenotypu III.
skos:notation	NB5986
http://linked.open...avai/cep/aktivita	Research and development in the sphere of nutrition, metabolic and endocrine diseases
http://linked.open...kovaStatniPodpora	http://linked.opendata.cz/resource/domain/vavai/projekt/NB5986/celkovaStatniPodpora
http://linked.open...ep/celkoveNaklady	http://linked.opendata.cz/resource/domain/vavai/projekt/NB5986/celkoveNaklady
http://linked.open...datumDodatniDoRIV	2003-07-31 (xsd:date)
http://linked.open...i/cep/druhSouteze	VS - Veřejná soutěž ve výzkumu a vývoji
http://linked.open...ep/duvernostUdaju	S - Úplné a pravdivé údaje nepodléhající ochraně podle zvláštních právních předpisů
http://linked.open.../cep/fazeProjektu	1140403
http://linked.open...ai/cep/hlavniObor	FB - Endokrinologie, diabetologie, metabolismus, výživa
http://linked.open...hodnoceniProjektu	V - Vynikající výsledky (s mezinárodním významem apod.). Zároveň byly splněny cíle a předpokládané výsledky uvedené ve smlouvě / rozhodnutí o poskytnutí podpory.
http://linked.open.../cep/klicovaSlova	genetics;familial hyperlipoproteinaemi;apolipoproteins AI, B, (a);hypolipidaemic therapy;cytoadhesive molecules;lipoprotein lipase;apoE and B genes polymorphism;endothelial dysfunction (en)
http://linked.open...ep/partnetrHlavni	Všeobecná fakultní nemocnice v Praze
http://linked.open...inujicichPrijemcu	0 (xsd:int)
http://linked.open...cep/pocetPrijemcu	1 (xsd:int)
http://linked.open...ocetSpoluPrijemcu	1 (xsd:int)
http://linked.open.../pocetVysledkuRIV	59 (xsd:int)
http://linked.open...enychVysledkuVRIV	59 (xsd:int)
http://linked.open...iciPoslednihoRoku	2003
http://linked.open...atUdajeProjZameru	2003
http://linked.open.../vavai/cep/soutez	SMZ0NB2000
http://linked.open...usZobrazovaneFaze	DUU
http://linked.open...ai/cep/typPojektu	P - Projekt výzkumu a vývoje financovaný ze státního rozpočtu
http://linked.open...jektu+dodavatelem	Pro české zdravotnictví znamenají výsledky výzkumného projektu další rpzšíření v oblasti diagnostiky a léčby poruch metabilizmu lipidů. (cs)
http://linked.open...tniCyklusProjektu	ZBKU
http://linked.open.../cep/klicoveSlovo	genetics lipoprotein lipase B (a) apoE and B genes polymorphism apolipoproteins AI cytoadhesive molecules familial hyperlipoproteinaemi hypolipidaemic therapy
is http://linked.open...vavai/riv/projekt of	Folate SupplemetationPrevents Plasma Homocysteine Increase After Fenofibrate Therapy Flow-Dependent Vasomotor Dysfunction of the Popliteal Artery Related to Common Carotid Artery Intima-Media Thickness Fibrates in the prevention of coronary heart disease in diabetic patients. Comments on the results of the DAIS study Mutation frequence of LPL gene in patients with hyperlipoproteinemia Folate supplementation prevents plasma homocysteine increase after fenofibrate therapy (3) Folate supplementation prevents plasma homocysteine increase after fenofibrate therapy (1) Folate supplementation prevents plasma homocysteine increase after fenofibrate therapy (2) Folate supplementation prevents plasma homocysteine increase after fenofibrate therapy Krátkodobá léčba LDL-aferézou u nemocných s hyperlipoproteinémií a ICHS: teoretická východiska a první zkušenosti Major apolipoprotein B-100 mutations in lipoprotein metabolism and atherosclerosis Indirect relation between intimo-medial thickness of arteria carotis and ability of arteria poplitea vasodilatation Bone mineral density in patients with apolipoproteine E type 2/2 and 4/4 genotpye. Familial defective apolipoprotein B 100: a lesson from homozygous and heterozygous patients. Fenofibrate 250 SR Pharmavit u nemocných se smíšenou hyperlipoproteinémií.Výsledky sledování u 189 nemocných ze 13 center v ČR. Postavení LDL-aferézy v terapii hyperlipoproteinémií. The relationship of flow-mediated vasodilatation to common carotid artery intimal thickness Simvastatin vs. pravastatin. Results of a Czech multicentric study Response of plasma lipids to hormone replacement therapy. Transdermal and oral ways of administration compared Simvastatin vs. pravastatin. Výsledky české multicentrické studie Vliv atorvastatinu na mikrocirkulaci a leukocytární expresi cytoadhezivních molekul The Ankle-Brachial blood pressure index as a risk indicator of generalized atherosclerosis Aktuální pohled na léčbu hyperlipidémií Hyperlipoproteinemias, atherosclerosis and cardiovascular diseases: Treatment of hyperlipidaemia Part II. Hyperlipoproteinemias, atherosclerosis and cardiovascular diseases: Pthogenesis and diagnostics Part I. HDL cholesterol ve světle nejnovějších poznatků a doporučení Familial dysbetalipoproteinaemia and structural variant apoE2*(Arg136Cys) Metabolický syndrom HDL-CH, diabetická dyslipidemie a kardiovaskulární riziko LPL gene variants in primary combined hyperlipidemia Treatment of hypertension in diabetic patiens with ACE inhibitor by trandolapril - multicentric study Effect of folic acid on fenofibrate-induced elevation of homocysteine and cysteine Effect of folic on fenofibrate-induced elevation of homocysteine and cysteine ApoE polymorphism and monogenic hypercholesterolemias Absence of the R3531C mutation in the apoB gene in Czech hypercholesterolaemic patients ApoE polymorphism in monogenic hypercholesterolemias and its influence on plasma lipid levels after statin treatment Predicting the coronary risk in primary and secondary prevention. What is the difference? Atorvastatin reduces leukocyte expression of cell adhesion molecules in patients with hypercholesterolemia Aterosklerosa a dyslipidémie Effect of atorvastatin on leukocyte expression of cell adhesion molecules in patients with hypercholesterolemia Effect of atorvastatin on microvascular reactivity in patients with hypercholesterolemia Kdy zahájit hypolipidemickou léčbu u nemocných s ICHS ? Microvascular reactivity in patients with hypercholesterolemia: Effect of atorvastatin treatment (2) Final report of the Grant Project NB 5986-3, Grant Agency, Ministery of Health, Czech Republic- Familial. hyperlipoproteinaemias Apolipoproteins and Atherosclerosis.Apolipoprotein E and Apolipoprotein (a) as Candidate Genes of Premature Development of Atherosclerosis. Snížení cholesterolu: víc než jen regrese aterosklerózy. Cholesterol lowering and the vessel wall: new insights and future perspectives PAPP-A, a novel marker of unstable plaque, is not influence by hypolipidemic treatment in contrast to CRP T-1131--C polymorphism whitin the apolipoprotein A V gene in hypertriglyceridemic individuals Atorvastatin and expression of leukocyte adhesion molecules in patients with hypercholesterolemia T-1131C polymorphism within the apolipoprotein AV gene in hypertriglyceridemic individuals Echinococcus multilocularis in European wolves (Canis lupus). Ultrasound of carotid arteries and the measurement of the intima-media thickness as an indicator of the generalised atherosclerosis Simvor in the treatment of hyperlipoproteinaemia Microvascular reactivity in patients with hypercholesterolemia: Effect of lipid lowering treatment Relationship of the intima-media thickness and atherosclerotic plaques of the carotid artery to coronary artery disease Secondary hyperlipidaemia Statiny rok poté. Zamyšlení nad léčbou statiny po cerivastatinovém skandálu. Jsou všechny statiny stejné ? Atorvastatin reduces expression of leukocyte adhesion molecules in patients with hypercholesterolemia Atorvastatin reduces expressiion of leukocyte adhesion molecules in patients with hypercholesterolemia Subclinical atherosclerosis
is http://linked.open...vavai/cep/projekt of	http://linked.opendata.cz/resource/domain/vavai/cep/ucast/NB5986/2007/ico%3A00064165 http://linked.opendata.cz/resource/domain/vavai/cep/ucast/NB5986/2007/orjk%3A11110

Faceted Search & Find service v1.16.118 as of Jun 21 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3240 as of Jun 21 2024, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (126 GB total memory, 58 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software